133 related articles for article (PubMed ID: 9796986)
1. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
Frank DK; Frederick MJ; Liu TJ; Clayman GL
Clin Cancer Res; 1998 Oct; 4(10):2521-8. PubMed ID: 9796986
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
3. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Wakasa T; Inoue T; Kuroda M; Shibuya K; Shigehara H; Kawasaki S; Fukui K; Kishi K; Hiraki Y
Oncol Rep; 2002; 9(6):1233-6. PubMed ID: 12375026
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
Overholt SM; Liu TJ; Taylor DL; Wang M; El-Naggar AK; Shillitoe E; Adler-Storthz K; John LS; Zhang WW; Roth JA; Clayman GL
Clin Cancer Res; 1997 Feb; 3(2):185-91. PubMed ID: 9815671
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
[TBL] [Abstract][Full Text] [Related]
7. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.
Rizk NP; Chang MY; El Kouri C; Seth P; Kaiser LR; Albelda SM; Amin KM
Cancer Gene Ther; 1999; 6(4):291-301. PubMed ID: 10419047
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
Eicher SA; Clayman GL; Liu TJ; Shillitoe EJ; Storthz KA; Roth JA; Lotan R
Clin Cancer Res; 1996 Oct; 2(10):1659-64. PubMed ID: 9816113
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant adenovirus expressing wild-type p53 is antiagiogenic--implication for lung cancer gene therapy].
Fujiwara T; Nishizaki M; Tanaka N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1217-24. PubMed ID: 10945020
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
Clayman GL; Frank DK; Bruso PA; Goepfert H
Clin Cancer Res; 1999 Jul; 5(7):1715-22. PubMed ID: 10430074
[TBL] [Abstract][Full Text] [Related]
15. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma].
Wang XL; Qian XL; Zhao QZ; Xu ZG; Tang PZ
Ai Zheng; 2003 Nov; 22(11):1140-6. PubMed ID: 14613640
[TBL] [Abstract][Full Text] [Related]
16. Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Konoucni H; Hisatomi M; Yanagi Y; Honda Y; Shigehara H; Kishi K
Oncol Rep; 2003; 10(2):415-20. PubMed ID: 12579282
[TBL] [Abstract][Full Text] [Related]
17. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector.
Dolivet G; Merlin JL; Barberi-Heyob M; Ramacci C; Erbacher P; Parache RM; Behr JP; Guillemin F
Cancer Gene Ther; 2002 Aug; 9(8):708-14. PubMed ID: 12136433
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL
Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883
[TBL] [Abstract][Full Text] [Related]
19. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
Morris JC; Wildner O
Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]